GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 6,770.00
+150.00 (2.27%)
May 21, 2026, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 156.57 billion as of May 21, 2026.
Market Cap
156.57B
Enterprise Value
120.47B
Revenue
31.53B
Ranking
n/a
PE Ratio
35.87
Stock Price
6,770.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 156.57B, a decrease of -40.36%. That is a compound annual growth rate of -42.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 160.12B | -0.73% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 61.89T |
| Celltrion | 37.60T |
| ALTEOGEN | 19.24T |
| Samsung Epis Holdings | 11.56T |
| Samil Pharmaceutical Co.,Ltd | 166.44B |
| Dongbang Medical | 165.38B |
| Dongwha Pharm.Co.,Ltd | 164.64B |
| Daihan Pharmaceutical | 162.29B |